These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25819934)

  • 1. Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders.
    Espejo-Porras F; Piscitelli F; Verde R; Ramos JA; Di Marzo V; de Lago E; Fernández-Ruiz J
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):233-44. PubMed ID: 25819934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the CB
    Rodríguez-Cueto C; Gómez-Almería M; García Toscano L; Romero J; Hillard CJ; de Lago E; Fernández-Ruiz J
    Brain Pathol; 2021 Nov; 31(6):e12972. PubMed ID: 33983653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting glial cannabinoid CB
    Espejo-Porras F; García-Toscano L; Rodríguez-Cueto C; Santos-García I; de Lago E; Fernandez-Ruiz J
    Br J Pharmacol; 2019 May; 176(10):1585-1600. PubMed ID: 29574689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of CB
    Fernández-Trapero M; Espejo-Porras F; Rodríguez-Cueto C; Coates JR; Pérez-Díaz C; de Lago E; Fernández-Ruiz J
    Dis Model Mech; 2017 May; 10(5):551-558. PubMed ID: 28069688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients.
    Espejo-Porras F; Fernández-Ruiz J; de Lago E
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Aug; 19(5-6):377-386. PubMed ID: 29334787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in endocannabinoid receptors and enzymes in the spinal cord of SOD1(G93A) transgenic mice and evaluation of a Sativex(®) -like combination of phytocannabinoids: interest for future therapies in amyotrophic lateral sclerosis.
    Moreno-Martet M; Espejo-Porras F; Fernández-Ruiz J; de Lago E
    CNS Neurosci Ther; 2014 Sep; 20(9):809-15. PubMed ID: 24703394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
    Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
    BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Re Attenuates Neuroinflammation in a Symptomatic ALS Animal Model.
    Cai M; Yang EJ
    Am J Chin Med; 2016; 44(2):401-13. PubMed ID: 27080948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
    Burgaz S; García C; Gonzalo-Consuegra C; Gómez-Almería M; Ruiz-Pino F; Unciti JD; Gómez-Cañas M; Alcalde J; Morales P; Jagerovic N; Rodríguez-Cueto C; de Lago E; Muñoz E; Fernández-Ruiz J
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice.
    Palomo-Garo C; Gómez-Gálvez Y; García C; Fernández-Ruiz J
    Pharmacol Res; 2016 Aug; 110():181-192. PubMed ID: 27063942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mislocalization of TDP-43 in the G93A mutant SOD1 transgenic mouse model of ALS.
    Shan X; Vocadlo D; Krieger C
    Neurosci Lett; 2009 Jul; 458(2):70-4. PubMed ID: 19379791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CB
    Gonzalo-Consuegra C; Santos-García I; García-Toscano L; Martín-Baquero R; Rodríguez-Cueto C; Wittwer MB; Dzygiel P; Grether U; de Lago E; Fernández-Ruiz J
    Biomed Pharmacother; 2024 May; 174():116473. PubMed ID: 38522237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
    Pryce G; Baker D
    Handb Exp Pharmacol; 2015; 231():213-31. PubMed ID: 26408162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
    Wang SY; Ren M; Jiang HZ; Wang J; Jiang HQ; Yin X; Qi Y; Wang XD; Dong GT; Wang TH; Yang YQ; Feng HL
    Neuroscience; 2015 Aug; 301():276-88. PubMed ID: 26067594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
    Cai M; Lee KW; Choi SM; Yang EJ
    Neurol Res; 2015 Mar; 37(3):253-62. PubMed ID: 25213598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.
    Santos-García I; Rodríguez-Cueto C; Villegas P; Piscitelli F; Lauritano A; Shen CJ; Di Marzo V; Fernández-Ruiz J; de Lago E
    J Neuroinflammation; 2023 May; 20(1):108. PubMed ID: 37149645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
    Ng SK; Higashimori H; Tolman M; Yang Y
    Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole Exhibits No Therapeutic Efficacy on a Transgenic Rat model of Amyotrophic Lateral Sclerosis.
    Chen S; Liao Q; Lu K; Zhou J; Huang C; Bi F
    Curr Neurovasc Res; 2020; 17(3):275-285. PubMed ID: 32271694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.